Condition
Amniocentesis Affecting Fetus or Newborn
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Completed2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05834621Withdrawn
AMNIOmics: A Prenatal Rapid Genome Validation Study
NCT04831086Phase 3Completed
To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis
NCT05463549Not ApplicableCompleted
The Effect of Exposure to an Informative Video About Amniocentesis Before the Procedure on Maternal Anxiety
Showing all 3 trials